POSID 100MG INJECTION
| Product Name | Posid Injection |
| Strength | 100 mg |
| Active Ingredient | Etoposide |
| Drug Class | Topoisomerase II Inhibitor |
| Form | Injection (solution for infusion) |
| Route of Administration | Intravenous infusion |
| Packaging | Single-use vial |
| Storage Condition | Store below 25°C and protect from light |
| Prescription Required | Yes |
| Usage | Lung cancer, testicular cancer, lymphomas |
POSID 100MG INJECTION
Posid 100mg Injection contains etoposide, a prescription chemotherapy drug classified as a topoisomerase II inhibitor. It is used in the treatment of small-cell lung cancer (SCLC), testicular cancer, lymphomas, and other malignancies to help control the growth of cancer cells.
Etoposide works by interfering with the DNA replication process in cancer cells, preventing them from dividing and multiplying. Posid 100mg Injection is administered via intravenous infusion under strict medical supervision in hospital or oncology clinic settings to ensure safe and effective treatment.
Posid 100mg Injection is offered through an established pharmaceutical distribution network. The product is handled according to proper storage and quality standards to maintain safety, potency, and dependable availability.
Product Features
- Anticancer etoposide chemotherapy injection
- Contains Etoposide 100 mg
- Used in lung cancer, testicular cancer, and lymphomas
- Topoisomerase II inhibitor
- Administered via IV infusion
- Suitable for hospital and oncology center use
- Manufactured under GMP-compliant standards
- Prescription-required medicine
How It Helps
- Inhibits topoisomerase II to prevent cancer cell division
- Slows the growth and spread of malignant cells
- Supports the treatment of lung cancer, testicular cancer, and lymphomas
- Helps improve the effectiveness of chemotherapy regimens





Reviews
There are no reviews yet.